Inventor · disambiguated record
Chung-Chiang Hsu
Also filed as: HSU CHUNG C · HSU CHUNG-CHIANG · HSU CHUNG-Y · SHIRE STEVEN J
20 granted patents·6 pending applications·2,883 citations·filing 1989–2024
96Inventor score
Top patents by PatentIndex Score
26 records- 0198US7682609B2Protein formulationGENENTECH INC·Filed 2006·Granted Mar 23, 2010·77 cites·30 claims
- 0298US7060268B2Protein formulationGENENTECH INC·Filed 2003·Granted Jun 13, 2006·208 cites·3 claims
- 0398US6821515B1Protein formulationGENENTECH INC·Filed 2000·Granted Nov 23, 2004·209 cites·23 claims
- 0498US6685940B2Protein formulationGENENTECH INC·Filed 2001·Granted Feb 3, 2004·402 cites·15 claims
- 0598US6267958B1Protein formulationGENENTECH INC·Filed 1996·Granted Jul 31, 2001·1.5k cites·47 claims
- 0695US9283273B2Protein formulationANDYA JAMES·Filed 2012·Granted Mar 15, 2016·20 cites·16 claims
- 0794US5653996AMethod for preparing liposomesGENENTECH INC·Filed 1995·Granted Aug 5, 1997·163 cites·28 claims
- 0893US9180189B2Treating a mammal with a formulation comprising an antibody which binds IgEANDYA JAMES·Filed 2005·Granted Nov 10, 2015·18 cites·4 claims
- 0989US11752096B2Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumorsAMMAX BIO INC·Filed 2022·Granted Sep 12, 2023·1 cites·18 claims
- 1089US5192743AReconstitutable lyophilized protein formulationGENENTECH INC·Filed 1992·Granted Mar 9, 1993·121 cites·13 claims
- 1188US11419822B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2021·Granted Aug 23, 2022·1 cites·13 claims
- 1282US11870828B2System, method and computer-readable medium for rendering a streaming17LIVE JAPAN INC·Filed 2022·Granted Jan 9, 2024·1 cites·21 claims
- 1380US2025073170A1High concentration formulations of anti-csf1 and anti-csf1r antibodiesAMMAX BIO INC·Filed 2024·Application pending·0 cites
- 1477US12178915B2High concentration formulations of anti-CSF1 and anti-CSF1R antibodiesAMMAX BIO INC·Filed 2022·Granted Dec 31, 2024·0 cites·10 claims
- 1577US5085864AInjectable formulation for lipophilic drugsABBOTT LAB·Filed 1991·Granted Feb 4, 1992·66 cites·9 claims
- 1674US12371501B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·11 claims
- 1772US2024016730A1Targeted delivery of anti-csf1r antibodiesAMMAX BIO INC·Filed 2023·Application pending·0 cites
- 1871US11427641B2Extended local release of anti-CSFR1 antibodiesAMMAX BIO INC·Filed 2022·Granted Aug 30, 2022·0 cites·5 claims
- 1971US5747002APreparation of sodium chloride aerosol formulationsGENENTECH INC·Filed 1995·Granted May 5, 1998·37 cites·7 claims
- 2063US2024098125A1System, method and computer-readable medium for rendering a streaming17LIVE JAPAN INC·Filed 2023·Application pending·0 cites
- 2159US2011236383A1Protein FormulationANDYA JAMES·Filed 2011·Application pending·0 cites
- 2258US5082656ATopical antibacterial compositions containing penetration enchancersABBOTT LAB·Filed 1989·Granted Jan 21, 1992·48 cites·11 claims
- 2358US2010158899A1Protein formulationGENENTECH INC·Filed 2010·Application pending·0 cites
- 2454US2005203082A1Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agentsFiled 2004·Application pending·0 cites
- 2543US10987303B2Extended release suspension formulation of lurasidoneLIFEMAX LABORATORIES INC·Filed 2019·Granted Apr 27, 2021·0 cites·6 claims
- 2637US5055399AEnzymatic synthesis of alpha-L-aspartyl-L-phenyalanine lower alkyl estersGENENTECH INC·Filed 1989·Granted Oct 8, 1991·3 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →